Participants
This experimental study was carried out as a randomized controlled clinical trial with a 1:1 allocation ratio in the heart departments of hospitals affiliated with the Kerman University of Medical Sciences from December 2021 to September 2022. The number and accessibility of patients were the deciding factors in selecting these centers.